erythromycin has been researched along with Infarction, Middle Cerebral Artery in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, ZZ; Li, GY; Lu, WC; Qiu, B; Xie, H; Yang, RM | 1 |
| Inaba, T; Katayama, Y; Katsura, K; Nito, C; Ueda, M | 1 |
| Inaba, T; Katayama, Y; Nito, C; Ueda, M | 1 |
3 other study(ies) available for erythromycin and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Erythromycin pretreatment induces tolerance against focal cerebral ischemia through up-regulation of nNOS but not down-regulation of HIF-1α in rats.
Topics: Animals; Brain; Brain Edema; Brain Ischemia; Disease Models, Animal; Down-Regulation; Erythromycin; Hypoxia-Inducible Factor 1, alpha Subunit; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Nitric Oxide Synthase Type I; Random Allocation; Rats, Wistar; RNA, Messenger; Severity of Illness Index; Up-Regulation | 2014 |
Neuroprotective effects of erythromycin on cerebral ischemia reperfusion-injury and cell viability after oxygen-glucose deprivation in cultured neuronal cells.
Topics: Animals; Brain Edema; Brain Ischemia; Cell Hypoxia; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Erythromycin; Glucose; Hemiplegia; Infarction, Middle Cerebral Artery; Male; Neuroimmunomodulation; Neurons; Neuroprotective Agents; Oxidative Stress; Random Allocation; Rats, Sprague-Dawley; Reperfusion Injury | 2014 |
Neuroprotective effects of erythromycin on ischemic injury following permanent focal cerebral ischemia in rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Blood Pressure; Body Temperature; Brain Edema; Brain Infarction; Brain Injuries; Calcium-Binding Proteins; Cerebrovascular Circulation; Deoxyguanosine; Disease Models, Animal; Erythromycin; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Microfilament Proteins; Neuroprotective Agents; Rats; Statistics, Nonparametric; Time Factors; Tumor Necrosis Factor-alpha | 2016 |